SCHEMBL27632452

SCHEMBL27632452

O=C(F)c1cc(O)nc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.48
AKR1C2 P52895 1/20 0.48
AKR1C1 Q04828 1/20 0.48
KDM4E B2RXH2 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
LMNA P02545 1/20 0.47
PDE10A Q9Y233 1/20 0.47
POLB P06746 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NCOA1 Q15788 1/20 0.45
NCOA3 Q9Y6Q9 1/20 0.45
DHODH Q02127 2/20 0.45
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
HTT P42858 2/20 0.42
USP2 O75604 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL662652 0.85 KDM4E (0.64) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL30172583 0.85 KDM4E (0.64) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL28267403 0.84 KDM4E (0.62) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL11329279 0.84 KDM4E (0.62) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL7328160 0.82 AKR1C3 (0.48) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL10202038 0.82 NPC1 (0.49) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL5202032 0.82 NCOA1 (0.65) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL28540684 0.78 KDM4E (0.50) AKR1C3AKR1C2AKR1C1KDM4ESMN1; SMN2
SCHEMBL663977 0.78 KDM4E (0.70) KDM4ESMN1; SMN2LMNAPOLBMEN1
SCHEMBL1308656 0.73 KMT2A (0.77) KDM4ESMN1; SMN2LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101475528-A Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof TAISHO PHARMACEUTICAL CO LTD (JP) 2009-07-08 CN disclosed
CN-100451004-C Pyrimidine derivatives ARENA PHARM INC (JP) 2009-01-14 CN disclosed
CN-1798736-A Novel quinoline, tetrahydroquinazoline and pyrimidine derivatives and methods of treatment related to their use ARENA PHARM INC (JP) 2006-07-05 CN disclosed